Could This Be the First Disease-Modifying Drug in Bronchiectasis?

By News Health
6 hours Ago

(MedPage Today) — CHICAGO — Brensocatib (Brinsupri) appeared to have a disease-modifying effect on structural lung changes in non-cystic fibrosis bronchiectasis at its higher dose, a CT substudy of the ASPEN trial showed.
At the 25-mg dose…

Source link : https://www.medpagetoday.com/meetingcoverage/chest/118083

Author :

Publish date : 2025-10-22 17:20:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Bad Gums Tied to Big Brain Risks

Novel T-Cell Therapy Promising in Tough-to-Treat Eye Cancer

'Alternative' to CDC's Flagship Journal in the Works

Can Steroids Be Stopped in Lupus Nephritis? Yes, and Here's How

A Peek Inside the Blue Medical Tent That Has Become a Fixture on NFL Sidelines

Ob/Gyns Urged to Fight Contraception Misinformation